Cerivastatin
Top View
- Statin-Related Myotoxicity: a Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
- 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
- Atorvastatin and Micronized Fenofibrate Alone and In
- 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (12) United States Patent (10) Patent No.: US 6,511,985 B1 Ippen Et Al
- Literature Update Week 10 (2021)
- Comparative Effects of Cerivastatin and Fenofibrate on the Atherogenic Lipoprotein Phenotype in Proteinuric Renal Disease
- Accessibility Improving Information Using Online Patient Drug Reviews
- With Statin, Fenofibrate Safer Than Gemfibrozil
- BAYCOL® (Cerivastatin Sodium Tablets)
- Statins for the Primary Prevention of Cardiovascular Events
- WO 2017/079755 Al 11 May 2017 (11.05.2017) P O P C T
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- 70011405 FPO Gemfibrozil Tablets USP Revised: July 2004 Rx Only
- Fibrate Safety & Metabolism
- Lipid Modification to Reduce Cardiovascular Risk
- HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do Not Include All the Information Needed to Use ZETIA Safely and Effectively
- Clinical Pharmacology & Therapeutics